NIH-funded research Fellowship grant

Investigating how TFAP4 affects lysosome function and tau-related brain diseases

Official title: Evaluation of TFAP4 regulation of lysosome biogenesis and modulation of tau pathology

Funded at Yale University · NIH-11066701 · Data updated 2026-11-12

This study is looking at how a protein called TFAP4 can help improve the way our cells clean up harmful proteins linked to Alzheimer's disease, with the hope of finding new ways to protect brain cells and help people with neurodegenerative conditions.

Quick facts

Grant typeFellowship grant
Study typeNIH-funded research
Funding institutionYale University
NIH-funded
Lab location1 site (New Haven, United States)
Project startSeptember 30, 2024
Project endSeptember 29, 2026
Funding year2024
Award (this year)$48,974
NIH project number1F31NS141258-01
Project IDNIH-11066701 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals diagnosed with Alzheimer's disease or related tauopathies.

Less likely to help

Patients with non-neurodegenerative conditions or those without tau pathology may not benefit from this research.

What this research studies

This research focuses on understanding the role of TFAP4 in regulating lysosome biogenesis, which is crucial for clearing toxic proteins associated with Alzheimer's disease and related tauopathies. By enhancing the autophagy-lysosome pathway, the study aims to find new therapeutic strategies to prevent or reduce neuron loss caused by toxic tau accumulation. The approach includes in vitro experiments to assess how manipulating TFAP4 levels can influence lysosomal function and potentially improve outcomes for patients with neurodegenerative diseases.

Why it matters

Potential benefit: If successful, this research could lead to new treatments that slow down or prevent the progression of Alzheimer's disease and related conditions.

How similar studies have gone: Previous research has shown promise in targeting lysosomal function to treat neurodegenerative diseases, indicating that this approach may be viable.

Where this research is happening

  • Yale University
    New Haven, United States
    Active

Researchers

  • Principal investigator: Owens, Ashley — Yale University
  • Study coordinator: Owens, Ashley

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Browse more
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.